{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:49:38Z","timestamp":1772016578503,"version":"3.50.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:00:00Z","timestamp":1288915200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013849","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T19:59:26Z","timestamp":1288987166000},"page":"e13849","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults"],"prefix":"10.1371","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct00057525","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bruce K.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"VanCott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Marovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya Santelli","family":"Antonille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly T.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raburn M.","family":"Mallory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Birx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation.","volume":"76","author":"JA Young","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.","volume":"19","author":"PF Fellows","year":"2001","journal-title":"Vaccine"},{"key":"ref3","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against <italic>Bacillus anthracis<\/italic> aerosol spore challenge in rhesus macaques.","volume":"87","author":"BE Ivins","year":"1996","journal-title":"Salisbury Med Bull"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.","volume":"16","author":"BE Ivins","year":"1998","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field Evaluation of a Human Anthrax Vaccine.","volume":"52","author":"PS Brachman","year":"1962","journal-title":"Am J Public Health Nations Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future.","volume":"9","author":"PC Turnbull","year":"1991","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.5.4.417","article-title":"Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.","volume":"5","author":"WA Keitel","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"ref8","article-title":"Anthrax Vaccine Adsorbed (Biothrax\u2122) package insert","year":"2008"},{"key":"ref9","first-page":"75180","article-title":"Biological products, bacterial vaccines and toxoids, implementation of efficacy review, anthrax vaccine adsorbed.","year":"2004"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.vaccine.2008.10.044","article-title":"Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.","volume":"27","author":"MT Niu","year":"2009","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.vaccine.2006.11.040","article-title":"\u201cImmunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial\u201d [Vaccine 24 (2006) 5950-5959].","volume":"25","author":"TK Zink","year":"2007","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1016\/j.vaccine.2007.08.010","article-title":"Response to letter to the editor \u201cZink TK. Vaccine 2007;25(15):2766-7\u201d.","volume":"25","author":"GJ Gorse","year":"2007","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.","volume":"24","author":"GJ Gorse","year":"2006","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.","volume":"3","author":"JD Campbell","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.","volume":"8","author":"CP Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.","volume":"190","author":"CP Quinn","year":"2004","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/386285","article-title":"Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.","volume":"189","author":"S Ratto-Kim","year":"2004","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","article-title":"Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.","volume":"24","author":"PR Pittman","year":"2006","journal-title":"Vaccine"},{"key":"ref19","article-title":"Anthrax Vaccine Adsorbed (Biothrax\u2122) package insert","year":"2002"},{"key":"ref20","first-page":"476","article-title":"The use of anthrax antigen to immunise man and monkey.","volume":"271","author":"FC Belton","year":"1956","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax.","volume":"19","author":"ML Pitt","year":"2001","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.","volume":"22","author":"SF Little","year":"2004","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine.","volume":"69","author":"S Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/504806","article-title":"Long-lasting T cell responses to biological warfare vaccines in human vaccinees.","volume":"43","author":"JS Allen","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/510312","article-title":"The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.","volume":"195","author":"DL Doolan","year":"2007","journal-title":"J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:00:37Z","timestamp":1588996837000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013849"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013849","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]}}}